By proceeding, you agree to our Terms of Use and Privacy Policy.
Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.
01-03 March 2022
Welcome to the 4th Chronic Kidney Disease Drug Development Summit (CKD3) The 4th Chronic Kidney Disease Drug Development Summit (CKD3) is the definitive industry forum dedicated to presenting actionable insights into how the latest scientific researc
Event Ended
USA
Paid
Boston